Knight Therapeutics Inc. (TSX:GUD)
5.83
-0.04 (-0.68%)
Oct 24, 2025, 4:00 PM EDT
Knight Therapeutics Revenue
Knight Therapeutics had revenue of 107.36M CAD in the quarter ending June 30, 2025, with 12.33% growth. This brings the company's revenue in the last twelve months to 384.56M, up 13.82% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.
Revenue (ttm)
384.56M
Revenue Growth
+13.82%
P/S Ratio
1.51
Revenue / Employee
516.19K
Employees
745
Market Cap
581.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 371.30M | 43.11M | 13.13% |
| Dec 31, 2023 | 328.20M | 34.64M | 11.80% |
| Dec 31, 2022 | 293.56M | 50.09M | 20.57% |
| Dec 31, 2021 | 243.48M | 43.96M | 22.03% |
| Dec 31, 2020 | 199.52M | 152.06M | 320.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| dentalcorp Holdings | 1.62B |
| Trulieve Cannabis | 1.62B |
| Green Thumb Industries | 1.57B |
| Extendicare | 1.51B |
| Verano Holdings | 1.16B |
| WELL Health Technologies | 1.12B |
| Sienna Senior Living | 929.68M |
Knight Therapeutics News
- 18 days ago - Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada - GlobeNewsWire
- 18 days ago - Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada - GlobeNewsWire
- 4 weeks ago - Knight Therapeutics Inc. places No. 384 on The Globe and Mail’s seventh annual ranking of Canada’s Top Growing Companies - Financial Post
- 4 weeks ago - Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies - GlobeNewsWire
- 2 months ago - Knight Therapeutics announces share buyback plan - Seeking Alpha
- 2 months ago - Knight Announces Normal Course Issuer Bid - GlobeNewsWire
- 2 months ago - Knight Therapeutics Inc. (KHTRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Knight Therapeutics Reports Second Quarter 2025 Results - GlobeNewsWire